534 filings
Page 11 of 27
6-K
NVCN
Neovasc Inc
24 Jan 20
Current report (foreign)
9:01am
6-K
NVCN
Neovasc Inc
22 Jan 20
Neovasc Reducer™ for Treatment of Refractory Angina Featured in Multiple Presentations in Germany
9:02am
6-K
NVCN
Neovasc Inc
21 Jan 20
Updates on Reducer and Tiara Programs Will be Presented at Advanced Cardiovascular Intervention 2020 Meeting
9:02am
6-K
NVCN
Neovasc Inc
15 Jan 20
Current report (foreign)
10:09am
6-K
NVCN
Neovasc Inc
14 Jan 20
Neovasc Inc. Investor Update
4:23pm
6-K
NVCN
Neovasc Inc
7 Jan 20
Form 51-102F3 Material Change Report
8:37am
6-K
NVCN
Neovasc Inc
6 Jan 20
Neovasc Announces Closing of $10 Million Registered Direct Offering Priced At-The-Market
3:05pm
6-K
NVCN
Neovasc Inc
3 Jan 20
Current report (foreign)
6:01am
SUPPL
NVCN
Neovasc Inc
3 Jan 20
Supplemental materials (foreign)
12:00am
6-K
NVCN
Neovasc Inc
2 Jan 20
Neovasc Announces $10 Million Registered Direct Offering Priced At-The-Market
10:32am
6-K
NVCN
Neovasc Inc
31 Dec 19
Current report (foreign)
7:01am
6-K
NVCN
Neovasc Inc
17 Dec 19
Current report (foreign)
7:05am
6-K
NVCN
Neovasc Inc
5 Dec 19
Neovasc Named Finalist in Questex's Fierce Innovation Awards LifeSciences Edition 2019
8:57am
6-K
NVCN
Neovasc Inc
26 Nov 19
Current report (foreign)
7:12am
6-K
NVCN
Neovasc Inc
25 Nov 19
Neovasc Reducer™ Featured During Therapy Development Program in Coburg and Session at Maria Cecilia Hospital in Cotignola
12:00am
6-K
NVCN
Neovasc Inc
19 Nov 19
Neovasc Tiara™ Progress Highlighted at PCR London Valves 2019
9:02am
6-K
NVCN
Neovasc Inc
12 Nov 19
Current report (foreign)
8:28am
6-K
NVCN
Neovasc Inc
7 Nov 19
Form 6-K for Neovasc Inc
5:01pm
6-K
NVCN
Neovasc Inc
7 Nov 19
Condensed Interim Consolidated Financial Statements
4:51pm
6-K
NVCN
Neovasc Inc
7 Nov 19
Neovasc Announces Third Quarter 2019 Financial Results
4:09pm